2024 CHEVROLET TRAVERSE RS BLACK 2.5L 4 - 1GNEVLKS6RJ144013 | $16,800
ⓘ Historical Archive
This vehicle was sold at COPART on August 26, 2026. We do not sell cars - we only provide auction history data.
Description
This is an entry presenting CHEVROLET TRAVERSE manufactured in 2024, represented by 1GNEVLKS6RJ144013 VIN number.The auction took place on COPART and it's latest price was $16,800. Below you can find more details about this vehicle, including engine type, damage, transmission and odometer.
Similar Cars
Other CHEVROLET TRAVERSE listings
Other cars with front end damage
Popular models Chevrolet
Market Price Comparison - 2024 CHEVROLET TRAVERSE
Average market prices based on 757 recent auction sales. Prices vary by condition, mileage, and location.
Note: These are median values from recent auction sales of 2024 CHEVROLET TRAVERSE. Europe prices are estimated and may vary by country. Actual prices depend on vehicle condition, mileage, and market conditions.
How this 2024 CHEVROLET TRAVERSE compares
Based on recorded auction sales of this model with front end damage over the last 36 months. Figures are estimates drawn from past sales, not a valuation. Transport costs are indicative market rates, not quotes.
- Against comparable sales
- $16,800 — 20% above the $13,988 median across 757 sales
- Against pre-damage value
- 61% below the $43,579 estimated retail value
- Front End damage
- Front End examples of this model sell at a $13,100 median, 6% below the model average (320 comparable sales)
- Mileage
- 24,923 mi — 6% above the 23,426 mi average for this group
- Keys
- Present
- Condition note
- Engine Starts
- Title
- Salvage Title
- Secondary damage
- Side
- Seller
- State Farm Insurance
- Nearest export port
- Savannah, roughly 500 mi — estimated $425-$600 to move it there by open carrier
Frequently Asked Questions - 2024 CHEVROLET TRAVERSE
Common questions about this vehicle and our auction data archive
Note: AutoBidCar is an archive service providing historical auction data. We do not sell vehicles or facilitate purchases. All information is provided for research purposes only.